Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Looking for a Bargain? 3 Biotech Stocks to Buy That Are Down 20%-60% in 2023

By Larry Ramer, InvestorPlace Contributor

Since the pharmaceutical sector is very lucrative in America, these biotech stock bargains can be very profitable. 

Buy Alert: 3 Solar Stocks Nearing Super Attractive Entry Points

By Larry Ramer, InvestorPlace Contributor

With solar poised to become the largest source of power in the world, here are three top solar stock picks to add to your portfolio.

ACHR Stock Alert: Archer Just Got a $142 Million Boost

By Larry Ramer, InvestorPlace Contributor

Archer Aviation (ACHR) stock is soaring today after the company announced new deals with the Pentagon worth up to $142 million.

If You Can Only Buy One Dividend Stock, It Better Be One of These 7 Names

By Larry Ramer, InvestorPlace Contributor

These seven best dividend stocks will eventually rally and they will pay investors to wait for them to do so. 

3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes

By Larry Ramer, InvestorPlace Contributor

Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits.

Load More